secwatch.observer — SEC 8-K summary
======================================

Issuer:     biote Corp. (BTMD)
CIK:        0001819253
Form:       8-K
Filed at:   2025-03-12T23:59:59+00:00
Accession:  0001193125-25-052946
Event type: earnings
Sentiment:  negative
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

biote Q4 2024 revenue up 9% to $49.8M; EPS falls to $0.10 from $0.18
--------------------------------------------------------------------

- Q4 2024 revenue $49.8M, procedure revenue $36.6M, net income $3.5M ($0.10 EPS) vs $12.1M ($0.18 EPS) a year ago.
- Full year 2024 revenue $197.2M (+6.4% YoY); net income $0.05M (vs net loss $2.8M in 2023).
- Adjusted EBITDA Q4 $15.1M (30.3% margin); full year $58.2M (29.5% margin).
- Gross profit margin improved to 71.8% Q4 (70.5% full year) on vertical integration of 503B facility.
- Cash and cash equivalents $39.3M at year-end; fiscal 2025 outlook provided but not detailed in excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819253/000119312525052946/0001193125-25-052946-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819253/000119312525052946/d936042d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-052946

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer